{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T04:08:58Z","timestamp":1750651738604},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mr. Godbless Mariki"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tanzania ranks as the fourth country in the world with respect to the number of sickle cell disease (SCD) births; it is also endemic to the human immunodeficiency virus (HIV) and the hepatitis B virus (HBV). This study was done to determine the prevalence of HIV and HBV infections among SCD patients in Dar es Salaam, Tanzania.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A multicenter hospital-based descriptive cross sectional study was carried out among participants aged\u2009\u2265\u200916 years with a proven diagnosis of SCD. Socio-demographic and clinical data were recorded. Blood samples were drawn for HIV and HBV diagnosis. All categorical variables were summarized into frequencies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 185\/325 (56.9\u2009%) females. The mean age (SD) was 23.0\u2009\u00b1\u20097.5 years. The prevalence of HIV was 1.8\u2009%; the prevalence of HBV was 1.2\u2009%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The prevalence of both HIV and HBV in SCD patients is no greater than in the general population of Dar es Salaam or Tanzania. For associations, a large study would be needed. From a detailed blood transfusion history of SCD patients we found no evidence that HIV or HBV infection was transmitted through blood transfusion.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06726-z","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T14:06:52Z","timestamp":1633010812000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The prevalence of human immunodeficiency and of hepatitis B viral infections is not increased in patients with sickle cell disease in Tanzania"],"prefix":"10.1186","volume":"21","author":[{"given":"Grace","family":"Shayo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Makundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Luzzatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"issue":"9861","key":"6726_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","volume":"381","author":"FB Piel","year":"2013","unstructured":"Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, et al. Global epidemiology of sickle haemoglobin in neonates: A contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142\u201351.","journal-title":"Lancet"},{"issue":"2","key":"6726_CR2","doi-asserted-by":"publisher","first-page":"e14699","DOI":"10.1371\/journal.pone.0014699","volume":"6","author":"J Makani","year":"2011","unstructured":"Makani J, Cox SE, Soka D, Komba AN, Oruo J, Mwamtemi H, et al. Mortality in sickle cell anemia in africa: a prospective cohort study in Tanzania. PLoS One. 2011;6(2):e14699.","journal-title":"PLoS One"},{"issue":"2","key":"6726_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/tmi.12428","volume":"20","author":"J Makani","year":"2015","unstructured":"Makani J, Soka D, Rwezaula S, Krag M, Mghamba J, Ramaiya K, et al. Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality. Trop Med Int Health. 2015;20(2):184\u20137.","journal-title":"Trop Med Int Health"},{"key":"6726_CR4","unstructured":"World Health Organization. Global Health Observatory (GHO) data: Prevalence of HIV among adults aged 15\u201349. 2018.\u00a0\u00a0https:\/\/www.who.int\/gho\/hiv\/epidemic_status\/prevalence_text\/en\/. Accessed 29 Dec\u00a02020."},{"key":"6726_CR5","unstructured":"Tanzania Ministry of Health Community Development, gender elderly and children. Tanzania HIV Impact Survey (THIS) 2017. Vol.\u00a01, Report.\u00a02017.\u00a0\u00a0https:\/\/phia.icap.columbia.edu\/wp-content\/uploads\/2017\/11\/Tanzania_SummarySheet_A4.English.v19.pdf"},{"key":"6726_CR6","unstructured":"World Health Organization. Global hepatitis report, 2017. Global Hepatitis Programme. Who. 2017. 68 p.\u00a0\u00a0https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255016\/9789241565455-eng.pdf?sequence=1&isAllowed=y%0Ahttps:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/%0Ahttp:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255016\/9789241565455eng.pdf"},{"key":"6726_CR7","doi-asserted-by":"crossref","unstructured":"Miller WC, Shao JF, Weaver DJ, Shimokura GH, Paul DA, Lallinger GJ. Seroprevalence of viral hepatitis in Tanzanian adults. Trop Med Int Health. 1998;3(9):757\u201363.","DOI":"10.1046\/j.1365-3156.1998.00289.x"},{"key":"6726_CR8","doi-asserted-by":"publisher","unstructured":"Matee MI, Sciences A, Magesa P, Hospital MN, Lyamuya E. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania. BMC Public Health. 2006;6:21. https:\/\/doi.org\/10.1186\/1471-2458-6-21.","DOI":"10.1186\/1471-2458-6-21"},{"key":"6726_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2007.11.009","volume":"48","author":"MS Sulkowski","year":"2008","unstructured":"Sulkowski MS. Viral hepatitis and HIV coinfection. J Hepatol. 2008;48:353\u201367.","journal-title":"J Hepatol"},{"key":"6726_CR10","doi-asserted-by":"crossref","unstructured":"Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009;49(SUPPL. 5).S138-45","DOI":"10.1002\/hep.22883"},{"issue":"7","key":"6726_CR11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1086\/507532","volume":"43","author":"V Levy","year":"2006","unstructured":"Levy V, Grant RM. HIV\/AIDS: antiretroviral therapy for hepatitis B virus\u2013HIV\u2013coinfected patients: promises and pitfalls. Clin Infect Dis. 2006;43(7):904\u201310.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"6726_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/2325957413508320","volume":"13","author":"EB Odera","year":"2014","unstructured":"Odera EB, Kwobah C, Stone G, Some F, Vreeman RC. Sickle cell disease and HIV. J Int Assoc Provid AIDS Care. 2014;13(2):113\u20136.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"5","key":"6726_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.19080\/AJPN.2017.02.555600","volume":"2","author":"JM Oleske","year":"2017","unstructured":"Oleske JM. Potential protective effect of sickle cell gene allele on HIV infection. Acad J Pediatr Neonatol. 2017;2(5):1\u20133.","journal-title":"Acad J Pediatr Neonatol"},{"key":"6726_CR14","doi-asserted-by":"crossref","unstructured":"Nouraie M, Nekhai S, Gordfile:\/\/\/C:\/Users\/User\/Desktop\/MY DISSERTATION\/sexuality and scd.pdfeuk VR. Sickle cell disease is associated with decreased HIV but higher HBV and HCV comorbidities in US hospital discharge records: a cross-sectional study. Sex Transm Infect. 2012;88(7):528\u201333.","DOI":"10.1136\/sextrans-2011-050459"},{"issue":"4","key":"6726_CR15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/cid\/ciu832","volume":"60","author":"ED a Owusu","year":"2014","unstructured":"Owusu ED a., Visser BJ, Nagel IM, Mens PF, Grobusch MP. The interaction between sickle cell disease and HIV infection: a systematic review. Clin Infect Dis. 2014;60(4):612\u201326.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"6726_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1517\/14740338.3.4.279","volume":"3","author":"F Lori","year":"2004","unstructured":"Lori F, Kelly LM, Foli A, Lisziewicz J. Safety of hydroxyurea in the treatment of HIV infection. Expert Opin Drug Saf. 2004;3(4):279\u201388.","journal-title":"Expert Opin Drug Saf."},{"issue":"9","key":"6726_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2165\/00002018-200326090-00002","volume":"26","author":"J Lisziewicz","year":"2003","unstructured":"Lisziewicz J, Foli A, Wainberg M, Lori F. Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns. Drug Saf. 2003;26(9):605\u201324.","journal-title":"Drug Saf"},{"issue":"5","key":"6726_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/01.inf.0000259953.79654.d0","volume":"26","author":"AP Kourtis","year":"2007","unstructured":"Kourtis AP, Bansil P, Johnson C, Meikle SF, Posner SF, Jamieson DJ. Children with sickle cell disease and human immunodeficiency virus-1 infection. Pediatr Infect Dis J. 2007;26(5):406\u201310.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"6726_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/sj.thj.6200310","volume":"4","author":"KG Koffi","year":"2003","unstructured":"Koffi KG, Sawadogo D, Meite M, Nanho DC, Tanoh ES, Attia AK, et al. Reduced levels of T-cell subsets CD4 + and CD8 + in homozygous sickle cell anaemia patients with splenic defects. Hematol J. 2003;4(5):363\u20135.","journal-title":"Hematol J"},{"key":"6726_CR20","unstructured":"Caribbean HIV\/AIDS Regional Training Network (CHART). HIV and sickle cell disease.\u00a0\u00a0http:\/\/www.chartcaribbean.org\/careofplwa\/pdfdcouments\/subpdf\/SectionIII\/HIVandSickleCellDisease.pdf."},{"issue":"8","key":"6726_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12098-007-0129-4","volume":"74","author":"LM Tshilolo","year":"2007","unstructured":"Tshilolo LM, Mukendi RK, Wembonyama SO. Blood transfusion rate in congolese patients with sickle cell anemia. Indian J Pediatr. 2007;74(8):735\u20138.","journal-title":"Indian J Pediatr"},{"issue":"2","key":"6726_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/2141-9248.105655","volume":"2","author":"A Ubesie","year":"2012","unstructured":"Ubesie A, Emodi I, Ikefuna A, Ilechukwu G, Ilechukwu G. Prevalence of human immunodeficiency virus transmission among transfused children with sickle cell anemia in Enugu Nigeria. Ann Med Health Sci Res. 2012;2(2):109\u201313.","journal-title":"Ann Med Health Sci Res"},{"issue":"3","key":"6726_CR23","first-page":"3","volume":"14","author":"F Ngo Sack","year":"2013","unstructured":"Ngo Sack F, Eboumbou C, Ngouadjeu E, Zouha\u00efratou H, Mbanya D. Prevalence of HIV seropositivity among sickle cell disease patients at the Yaound\u00e9 Central Hospital. Health Sci Dis. 2013;14(3):3\u20137.","journal-title":"Health Sci Dis"},{"key":"6726_CR24","unstructured":"National Bureau of Statistics. 2012 Population and housing census. Zanzibar; 2013.\u00a0\u00a0http:\/\/www.tzdpg.or.tz\/fileadmin\/documents\/dpg_internal\/dpg_working_groups_clusters\/cluster_2\/water\/WSDP\/Background_information\/2012_Census_General_Report.pdf"},{"key":"6726_CR25","unstructured":"Tanzania National AIDS Control Program (NACP). Guidelines for HIV testing and counselling in clinical settings. online. 2007.\u00a0\u00a0http:\/\/www.who.int\/hiv\/topics\/vct\/TZ_PITC-Guidelines_finaledit_July2007.pdf."},{"key":"6726_CR26","unstructured":"National Bureau of Statistics. Tanzania HIV Impact Survey (THIS) 2016\u20132017. Tanzania HIV Impact Survey (THIS) 2016\u20132017. 2018.\u00a0\u00a0https:\/\/phia.icap.columbia.edu\/wp-content\/uploads\/2019\/06\/FINAL_THIS-2016-2017_Final-Report__06.21.19_for-web_TS.pdf"},{"issue":"3","key":"6726_CR27","first-page":"3","volume":"14","author":"NS Fran\u00e7oise","year":"2013","unstructured":"Fran\u00e7oise NS, Carole E, Evelyne N, Haman Z, Dora M. Prevalence of HIV seropositivity among sickle cell disease patients at the Yaound\u00e9 Central Hospital. Health Sci Dis. 2013;14(3):3\u20137.","journal-title":"Health Sci Dis"},{"issue":"3","key":"6726_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.trstmh.2010.11.007","volume":"105","author":"JPM Neto","year":"2011","unstructured":"Neto JPM, Lyra IM, Reis MG, Goncalves MS. The association of infection and clinical severity in sickle cell anaemia patients. Trans R Soc Trop Med Hyg. 2011;105(3):121\u20136. https:\/\/doi.org\/10.1016\/j.trstmh.2010.11.007.","journal-title":"Trans R Soc Trop Med Hyg."},{"issue":"8","key":"6726_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12098-007-0129-4","volume":"74","author":"LM Tshilolo","year":"2007","unstructured":"Tshilolo LM, Mukendi RK, Wembonyama SO. Blood transfusion rate in congolese patients with sickle cell anemia. Indian J Pediatr. 2007;74(8):735\u20138.","journal-title":"Indian J Pediatr"},{"key":"6726_CR30","doi-asserted-by":"crossref","unstructured":"Kilonzo SB, Gunda DW, Kashasha F, Mpondo BC. Liver fibrosis and Hepatitis B coinfection among ART Naive HIV-infected patients at a tertiary level hospital in Northwestern Tanzania: a cross-sectional study. J Trop Med. 2017;2017.","DOI":"10.1155\/2017\/5629130"},{"issue":"1","key":"6726_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/1596-4078.171378","volume":"15","author":"L Eberechukwu","year":"2015","unstructured":"Eberechukwu L, Ide Y, Babatunde S, Health C, Hospital HT, Harcourt P. Hepatitis B, C and human immunodeficiency virus (HIV) co-infection in nigerian children with sickle cell anaemia. Niger Heal J. 2015;15(1):18\u201323.","journal-title":"Niger Heal J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06726-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06726-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06726-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T14:07:31Z","timestamp":1633010851000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06726-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6726"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06726-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"assertion":[{"value":"9 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the Muhimbili University of Health and Allied Sciences (MUHAS), Research and Publication Ethical Committee. Permission to conduct the study was obtained from the administration of MNH, Temeke, Mwananyamala and Amana hospitals. All patients provided a written informed consent. Patients diagnosed with HIV and\/or HBV were referred to respective clinics for treatment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1028"}}